Overview and Scope
Coronary atherectomy devices are used to remove atherosclerosis from coronary blood vessels. Atherectomy devices were developed to permit drilling, grinding, or sanding of atheroma, calcium, and excess cellular material from the site of coronary occlusion or stenosis.
Sizing and Forecast
The coronary atherectomy devices market size has grown rapidly in recent years. It will grow from <b>$0.2 billion in 2023 to $0.22 billion in 2024 at a compound annual growth rate (CAGR) of 10.2%. </b> The growth in the historic period can be attributed to rising prevalence of coronary artery disease, growing demand for minimally invasive procedures, demand for coronary atherectomy devices, rising disposable incomes.
The coronary atherectomy devices market size is expected to see strong growth in the next few years. It will grow to <b>$0.31 billion in 2028 at a compound annual growth rate (CAGR) of 9.2%. </b> The growth in the forecast period can be attributed to aging population, hybrid procedures, industry investment, patient and physician awareness. Major trends in the forecast period include advancements in coronary atherectomy devices, miniaturization, enhanced imaging, personalized treatment, advancements in device design, robotics and artificial intelligence.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/coronary-atherectomy-devices-global-market-report
Segmentation & Regional Insights
The coronary atherectomy devices market covered in this report is segmented –
1) By Product: Directional Atherectomy Devices, Orbital Atherectomy Devices, Photo-Ablative Atherectomy Devices, Rotational Atherectomy Devices, Other Products
2) By Application: Peripheral Vascular, Cardiovascular, Neurovascular
3) By End User: Hospitals & Surgical Centers, Ambulatory Care Centers, Research Laboratories & Academic Institutes
<b>North America</b> was the largest region in the coronary atherectomy devices market in 2023. <b>Western Europe</b> was the second-largest region in the global coronary atherectomy devices market share. Africa, was the smallest region in the coronary atherectomy devices industry. The regions covered in the coronary atherectomy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3345&type=smp
Major Driver Impacting Market Growth
The increasing prevalence of cardiovascular diseases (CVDs) has resulted in an increased demand for atherectomy devices for the treatment of CVDs. The increased prevalence of cardiovascular diseases can be attributed to the use of smoking, physical inactivity, and an unhealthy diet. For instance, in September 2023, according to the Center for Disease Control and Prevention, a US-based government agency, the number of deaths due to cardiovascular diseases reached 695,547 in 2021. Additionally, in August 2022, according to the American College of Cardiology, a US-based non-profit medical association, the risk factors for ischemic heart disease were predicted to increase by 30.7% to 29 million by 2025. Therefore, increasing the prevalence of cardiovascular diseases is expected to drive the growth of the global coronary atherectomy devices market.
Key Industry Players
Major companies operating in the coronary atherectomy devices market include <b> Boston Scientific Corporation, Koninklijke Philips N.V., Cardiovascular Systems Inc., The Spectranetics Corporation, Medtronic Inc., Avinger Inc., Biotronik SE & Co KG, Arterial Remodeling Technologies, Atrium Medical Corporation, B. Braun Melsungen AG, Balton Sp. z o.o., Biosensors International Group Ltd., Straub Medical AG, C.R. Bard Inc., RA Medical Systems Inc., Shockwave Medical Inc., Terumo Corporation, Abbott Laboratories Inc., Asahi Intecc Co. Ltd., Baylis Medical Company Inc., Cook Medical LLC, Cordis Corporation, Edwards Lifesciences Corporation, Endologix Inc., Infraredx Inc., Intact Vascular Inc., Lutonix Inc., Mercator MedSystems Inc., Miracor Medical Systems GmbH, OrbusNeich Medical Company Limited, QT Vascular Ltd., TriReme Medical LLC, Vascular Solutions Inc., Volcano Corporation </b>
The coronary atherectomy devices market report table of contents includes:
1. Executive Summary
2. Coronary Atherectomy DevicesMarket Characteristics
3.Coronary Atherectomy Devices Market Trends And Strategies
4.Coronary Atherectomy Devices Market analysis
5.Coronary Atherectomy Devices Market Size And Growth
6Coronary Atherectomy Devices. Segmentation
7.Coronary Atherectomy Devices Regional And Country Analysis
.
.
.
27.Coronary Atherectomy Devices Competitive Landscape And Company Profiles
28.Coronary Atherectomy Devices Key Mergers And Acquisitions
29.Coronary Atherectomy Devices Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- Boston Scientific Corporation
- Koninklijke Philips N.V.
- Cardiovascular Systems Inc.
- The Spectranetics Corporation,
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
